Siemens Healthineers to Acquire Varian Medical Systems
August 2, 2020
Siemens Healthineers AG has agreed to acquire all shares of Varian Medical Systems, Inc. for USD 177.50 per share, valuing the deal at approximately USD 16.4 billion. The transaction, which aims to create an integrated cancer-care portfolio, is expected to close in H1 2021 subject to Varian shareholder and regulatory approvals.
- Buyers
- Siemens Healthineers AG
- Targets
- Varian Medical Systems, Inc.
- Sellers
- Varian Medical Systems shareholders
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Varian Medical Systems to Acquire Cancer Treatment Services International from TPG Growth
May 20, 2019
Healthcare Services
Varian Medical Systems has signed a definitive agreement to acquire Cancer Treatment Services International (CTSI) from TPG Growth / Asia Healthcare Holdings for $283 million. CTSI operates a network of oncology hospitals, diagnostic and treatment services across India and South Asia (including the American Oncology Institute and AmPath), employs more than 1,500 people, and the deal is expected to close in roughly two weeks subject to customary conditions.
-
Varian (Siemens Healthineers) Acquires Aspekt Solutions from L2 Capital
April 30, 2024
Healthcare Services
Varian, a Siemens Healthineers company, has acquired Aspekt Solutions, a provider of medical physics, dosimetry and radiation oncology consulting and staffing services. The seller was L2 Capital, which realized its 2017 investment in the business; terms were not disclosed. The acquisition expands Varian's Advanced Oncology Solutions offerings and its ability to deliver customized clinical and operational support to oncology providers.
-
Novartis to Acquire MorphoSys in $2.9 Billion Deal
February 7, 2024
Pharmaceuticals
Novartis agreed to a voluntary public takeover offer to acquire MorphoSys AG for €68 per share, valuing the deal at about €2.7 billion (reported as $2.9 billion). The acquisition is intended to expand and complement Novartis’ oncology pipeline, including pelabresib (CPI-0610) and tulmimetostat (CPI-0209).
-
Agilent Technologies to Acquire Biocare Medical for $950 Million
March 9, 2026
Healthcare Services
Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, in an all-cash transaction valued at $950 million. The deal is designed to expand Agilent’s pathology portfolio—especially immunohistochemistry—and is expected to close no later than Agilent’s fourth fiscal quarter of 2026.
-
Siemens Industry Software Acquires Altair Engineering
March 26, 2025
AI & Machine Learning
Siemens has signed an agreement to acquire Altair Engineering Inc. for $113 per share in cash, valuing the deal at about USD 10 billion. The transaction will combine Altair’s simulation, HPC, data science and AI capabilities with Siemens Xcelerator to create a more comprehensive AI-powered industrial software and digital twin portfolio.
-
HEALWELL AI to Acquire VeroSource Solutions
June 11, 2024
Healthcare Services
HEALWELL AI Inc. has agreed to acquire VeroSource Solutions Inc. for total consideration of approximately $24.5 million in a two-step transaction (initial ~51% on July 1, 2024 and remaining ~49% expected about January 1, 2025), payable in cash, HEALWELL subordinate voting shares and a performance-based earn-out. VeroSource, a Canadian health-data interoperability and digital-front-door platform serving provincial health clients, is expected to generate over $8 million in 2024 with strong recurring revenue and margins and will expand HEALWELL's population-health and AI-driven capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.